IMC Chicago’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$568M Buy
1,175,900
+549,000
+88% +$146M 0.14% 109
2026
Q1
$68.7M Sell
626,900
-105,800
-14% -$15.1M 0.02% 400
2025
Q4
$122M Buy
732,700
+32,200
+5% +$5.39M 0.04% 254
2025
Q3
$137M Buy
700,500
+229,200
+49% +$37.7M 0.05% 206
2025
Q2
$42.6M Buy
471,300
+141,600
+43% +$11.2M 0.02% 438
2025
Q1
$19.7M Sell
329,700
-19,100
-5% -$1.77M 0.01% 591
2024
Q4
$46.2M Buy
348,800
+131,000
+60% +$12.3M 0.02% 369
2024
Q3
$11.4M Buy
217,800
+81,400
+60% +$3.82M 0.01% 761
2024
Q2
$8.25M Buy
136,400
+56,100
+70% +$3.89M 0.01% 852
2024
Q1
$5.96M Buy
+80,300
New +$5.95M ﹤0.01% 905

Other funds holding ALAB

IMC Chicago's ALAB Position: Q2 2026 in Review

IMC Chicago sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 176,073 shares — an estimated $46.7M sold.

IMC Chicago first reported a position in ALAB in Q4 2024 and held it in 6 quarters. The position peaked at $32.3M in Q4 2025. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • IMC Chicago reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 176,073 Astera Labs shares in Q2 2026, an estimated $46.7M.
  • IMC Chicago first reported a position in Astera Labs in Q4 2024 and held it in 6 quarters.
  • IMC Chicago's Astera Labs position peaked at $32.3M in Q4 2025.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.